529 related articles for article (PubMed ID: 33693008)
1. Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus.
Tseng CH
Front Med (Lausanne); 2020; 7():592901. PubMed ID: 33693008
[No Abstract] [Full Text] [Related]
2. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
Tseng CH
J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
[TBL] [Abstract][Full Text] [Related]
3. Metformin reduces risk of varicose veins in patients with type 2 diabetes.
Tseng CH
Diabetes Metab Res Rev; 2020 Feb; 36(2):e3206. PubMed ID: 31322821
[TBL] [Abstract][Full Text] [Related]
4. Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Front Pharmacol; 2020; 11():578831. PubMed ID: 33664665
[No Abstract] [Full Text] [Related]
5. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
[TBL] [Abstract][Full Text] [Related]
6. Metformin and the Risk of Dementia in Type 2 Diabetes Patients.
Chin-Hsiao T
Aging Dis; 2019 Feb; 10(1):37-48. PubMed ID: 30705766
[TBL] [Abstract][Full Text] [Related]
7. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
Tseng CH
BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
[TBL] [Abstract][Full Text] [Related]
9. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
[No Abstract] [Full Text] [Related]
10. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
Tseng CH
Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
[TBL] [Abstract][Full Text] [Related]
11. Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes.
Tseng CH
Front Oncol; 2020; 10():587666. PubMed ID: 33194743
[TBL] [Abstract][Full Text] [Related]
12. Metformin and risk of chronic obstructive pulmonary disease in diabetes patients.
Tseng CH
Diabetes Metab; 2019 Apr; 45(2):184-190. PubMed ID: 29804817
[TBL] [Abstract][Full Text] [Related]
13. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
Tseng CH
J Crohns Colitis; 2021 Jan; 15(1):64-73. PubMed ID: 32604412
[TBL] [Abstract][Full Text] [Related]
14. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
Tseng CH
Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
[TBL] [Abstract][Full Text] [Related]
15. Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients.
Tseng CH
Ther Adv Endocrinol Metab; 2019; 10():2042018819895159. PubMed ID: 31897287
[TBL] [Abstract][Full Text] [Related]
16. Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
Tseng CH
Eur J Endocrinol; 2019 Jun; 180(6):365-372. PubMed ID: 30986765
[TBL] [Abstract][Full Text] [Related]
17. Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients.
Tseng CH
J Clin Med; 2018 Sep; 7(9):. PubMed ID: 30205606
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Sep; 7(38):62687-62696. PubMed ID: 27409676
[TBL] [Abstract][Full Text] [Related]
19. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
[TBL] [Abstract][Full Text] [Related]
20. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
